ArticleThe Journal of clinical investigation2019

PI3K p110δ inactivation antagonizes chronic lymphocytic leukemia and reverses T cell immune suppression.

Shuai Dong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.